おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Altos Labs
company
About
Altos Labs focuses on cellular rejuvenation programming to restore cell health and resilience, to reverse disease to transform medicine.
- 101 - 250
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $3B
- Industries
- Biopharma,Biotechnology
- Founded date
- Jan 1, 2021
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Altos Labs is a new biotechnology company focused on cellular rejuvenation programming to restore cell health and resilience, with the goal of reversing disease to transform medicine.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$3B
Altos Labs has raised a total of
$3B
in funding over 2 rounds. Their latest funding was raised on
Jan 1, 2021 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 1, 2021 | Series A | $3B | 1 | — | — | Detail |
Investments
Number of Investments
Number of Lead Investments
2
0
Altos Labs has made 2 investments. Their most recent investment was on
Oct 10, 2022, when Ludenso raised $1M.
Investors
Number of Lead Investors
Number of Investors
—
1
Altos Labs is funded by 1 investors.
ARCH Venture Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
ARCH Venture Partners
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
